The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of 10X Genomics GEM-X 5’ Gene Expression Reagents. This acquisition aims to support ongoing clinical trials focused on understanding the pathogenesis of B and T cells in individuals living with HIV, which could lead to significant advancements in HIV treatment and potential cures. The required reagents are critical for analyzing transcriptional activities in lymphocyte subsets, and failure to procure these items may jeopardize the data collection and analysis of taxpayer-funded research. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 22, 2025, at 10:00 AM EST, and can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at TALEXANDER@NIAID.NIH.GOV for further information.